DEMG vs. NIOX, SN, MXCT, EKF, CREO, IUG, NCYT, IHC, POLX, and AVO
Should you be buying Deltex Medical Group stock or one of its competitors? The main competitors of Deltex Medical Group include NIOX Group (NIOX), Smith & Nephew (SN), MaxCyte (MXCT), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), and Advanced Oncotherapy (AVO). These companies are all part of the "medical devices" industry.
Deltex Medical Group vs.
Deltex Medical Group (LON:DEMG) and NIOX Group (LON:NIOX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.
Deltex Medical Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.
NIOX Group has a net margin of 28.21% compared to Deltex Medical Group's net margin of -72.49%. NIOX Group's return on equity of 13.29% beat Deltex Medical Group's return on equity.
In the previous week, Deltex Medical Group and Deltex Medical Group both had 1 articles in the media. Deltex Medical Group's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.
Deltex Medical Group received 58 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 64.84% of users gave Deltex Medical Group an outperform vote.
NIOX Group has higher revenue and earnings than Deltex Medical Group. Deltex Medical Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.
18.9% of Deltex Medical Group shares are held by institutional investors. Comparatively, 35.2% of NIOX Group shares are held by institutional investors. 67.7% of Deltex Medical Group shares are held by company insiders. Comparatively, 46.7% of NIOX Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
NIOX Group beats Deltex Medical Group on 11 of the 13 factors compared between the two stocks.
Get Deltex Medical Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for DEMG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Deltex Medical Group Competitors List
Related Companies and Tools
This page (LON:DEMG) was last updated on 2/22/2025 by MarketBeat.com Staff
